Skip to main content

Scoliosis Idiopathic

0
Pipeline Programs
3
Companies
4
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
2 programs
Anterior Vertebral Body TetheringN/A1 trial
CastingN/A1 trial
Active Trials
NCT04914507Recruiting106Est. Sep 2029
NCT04500041Active Not Recruiting71Est. Sep 2026
ZimVie
ZimVieCO - Westminster
1 program
Anterior Vertebral Body TetheringN/A1 trial
Active Trials
NCT04505579Recruiting200Est. Dec 2027
HighRidge Medical
HighRidge MedicalCO - Westminster
1 program
Vertebral Body TetheringN/A1 trial
Active Trials
NCT05830825Recruiting100Est. Dec 2033

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
HighRidge MedicalVertebral Body Tethering
Spine BioPharmaAnterior Vertebral Body Tethering
Spine BioPharmaCasting
ZimVieAnterior Vertebral Body Tethering

Clinical Trials (4)

Total enrollment: 477 patients across 4 trials

NCT05830825HighRidge MedicalVertebral Body Tethering

PMCF (Post-Market Clinical Follow-up) Study on The Tether™ in UK (United Kingdom)

Start: Jul 2024Est. completion: Dec 2033100 patients
N/ARecruiting
NCT04914507Spine BioPharmaAnterior Vertebral Body Tethering

A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering

Start: Sep 2021Est. completion: Sep 2029106 patients
N/ARecruiting
NCT04500041Spine BioPharmaCasting

Casting vs Bracing for Idiopathic Early-Onset Scoliosis

Start: Feb 2021Est. completion: Sep 202671 patients
N/AActive Not Recruiting
NCT04505579ZimVieAnterior Vertebral Body Tethering

The Tether™ - Vertebral Body Tethering System Post Approval Study

Start: Oct 2020Est. completion: Dec 2027200 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 477 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.